<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="spike protein and cleaved spike (S2 subunit), respectively. TMPRSS2 inhibitors," exact="camostat" post="and nafamostat, blocked entry of SARSâ€�CoV-2 but not VSV."/>
 <result pre="Caluâ€�3 cells were treated with 10Â Î¼M camostat, 10Â Î¼M" exact="nafamostat" post="or DMSO for 1Â h. Then, the cells were"/>
 <result pre="human lung epithelial cell line Caluâ€�3 treated with TMPRSS2 inhibitors" exact="camostat" post="and nafamostat (FigÂ EV1D). SARSâ€�CoVâ€�2 pseudovirus infection was abolished"/>
 <result pre="epithelial cell line Caluâ€�3 treated with TMPRSS2 inhibitors camostat and" exact="nafamostat" post="(FigÂ EV1D). SARSâ€�CoVâ€�2 pseudovirus infection was abolished in cells"/>
 <result pre="numbers of EGFPâ€�positive cells, pretreated with 25HC as compared with" exact="ethanol" post="(EtOH) vehicle, and challenged with EGFPâ€�expressing pseudovirus (FigÂ 2B)."/>
 <result pre="Â±Â SD of nÂ =Â 3. *PÂ 0.05. FTMPRSS2 inhibitors" exact="camostat" post="blocked entry of SARSâ€�CoV and MERSâ€�CoV pseudoviruses. Caluâ€�3 cells"/>
 <result pre="and MERSâ€�CoV pseudoviruses. Caluâ€�3 cells were treated with 10Â Î¼M" exact="camostat" post="or DMSO for 1Â h. Then the cells were"/>
 <result pre="Cathepsin B/L and compared with DMSO control. We found that" exact="camostat" post="mesylate, a TMPRSS2 inhibitor, dramatically reduced viral entry in"/>
 <result pre="plasma membrane of 25HCâ€�treated cells. Caluâ€�3 cells were pretreated with" exact="ethanol" post="or 5Â Î¼M 25HC for 1Â h. Cells were"/>
 <result pre="MERSâ€�CoV pseudovirus into 25HCâ€�treated Caluâ€�3 cells. Cells were pretreated with" exact="ethanol" post="or 5Â Î¼M 25HC for 16Â h, washed, and"/>
 <result pre="lung epithelial cells. Caluâ€�3 cells were treated with 10Â Î¼M" exact="camostat" post="or 25Â Î¼M Eâ€�64D for 1Â h. Then, the"/>
 <result pre="25HC and TMPRSS2 inhibitor to block SARSâ€�CoV-2 entry. Addition of" exact="Nafamostat" post="in 25HCâ€�treated cells were infected with SARSâ€�CoV-2 pseudovirus and"/>
 <result pre="SARSâ€�CoVâ€�2. To address this question, Caluâ€�3 cells were pretreated with" exact="ethanol" post="or 25HC and challenged with SARSâ€�CoV or MERSâ€�CoV pseudoviruses"/>
 <result pre="in medium containing 2% LPDS prior to the treatment of" exact="ethanol" post="or 5Â Î¼M 25HC for 16Â h. Subsequently, cells"/>
 <result pre="40Â Î¼M SZ58â€�035 for 16Â h, prior to treatment with" exact="ethanol" post="or 2.5Â Î¼M 25HC for 1Â h. Cells were"/>
 <result pre="rescues viral entry viral entry. Caluâ€�3 cells were pretreated with" exact="ethanol" post="or 5Â Î¼M 25HC for 16Â h in the"/>
 <result pre="ACAT1 and ACAT2. 48Â h postâ€�transduction, cells were treated with" exact="ethanol" post="or 5Â Î¼M 25HC for 16Â h. Then, the"/>
 <result pre="USAâ€�WA1/2020 strain infection in Caluâ€�3 cells. Cells were pretreated with" exact="ethanol" post="or 25HC followed by infection. At 48Â h postâ€�infection,"/>
 <result pre="waterâ€�soluble cholesterol, and Sandoz 58â€�035 were obtained from Sigma. Camostat," exact="nafamostat" post="and Eâ€�64d were purchased from Selleck Chemicals. VSV pseudovirus"/>
 <result pre="inoculum. 2Â days postâ€�inoculation, cells were washed and stained with" exact="crystal violet." post="Plaque numbers were counted and used to calculate virus"/>
 <result pre="and Sandoz 58â€�035 rescue assays Caluâ€�3 cells were pretreated with" exact="Ethanol" post="or 5Â Î¼M 25HC for 16Â h. For cholesterol"/>
 <result pre="LiH, LuoJ (2020) An experimental trial of recombinant human interferon" exact="alpha" post="nasal drops to prevent coronavirus disease 2019 in medical"/>
</results>
